The aberrant expression of LPA receptors, particularly LPAR2 and LPAR3, has been reported in several cancers, suggesting a significant role for LPA in different cancer types through distinct signaling pathways such as AKT, MAPK, and ERK [15]. This evidence concerns the gene LPAR3 and cancer.